Breast Cancer

A new study published in The Lancet shows that one group could reduce their risk of colorectal cancer from taking the pill on a daily basis.

Afinitor (exemestane) and an aromatase inhibitor delay cancer growth in metastatic breast cancer.

A phase 3 randomized trial of two hormone therapies showed that in some postmenopausal women with hormone-positive metastatic breast cancer, the combo improves survival.

Women receiving a supportive care drug to reduce bone loss caused by breast cancer treatment may actually be getting more than that—improved survival and lower risk of metastatic recurrence.

Scientists research whether cancer stem cells are the key to eradicating the disease.

No rest for advocates who’ve made cancer their mission.

Aromasin (exemestane) reduces the risk of post-menopausal breast cancer.

Study shows flaxseed doesn't help with hot flashes.

Recent studies link vitamin D and folate intake to colon cancer risk reduction.

Regional lymph node radiation could benefit certain patients.

Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention.

Latest study results on PARP inhibitor iniparib disappointing, but may be helpful in second-line therapy.

Once again, when it comes to surgery to treat breast cancer, less has been shown to be more.

CURE's Lena Huang sits down with actress Cynthia Nixon to discuss how cancer has affected her life.

Early trial shows botanical for advanced breast cancer ready for next step.

ColoPrint gene assay can help guide treatment options for some colorectal patients, study shows.

The latest in cancer prevention, diagnosis and treatment.

Patients and the FDA battle over Avastin's breast cancer indication.

Understanding breast cancer biology provides some new targets.

A review of the fifth and latest version of Dr. Susan Love's Breast Book.

Connecticut and New York enact laws that require physicians to better communicate breast health information.

New directions in surgery, treatment and reconstruction are changing breast cancer.

Sentinel node biopsy reduces complications of breast surgery.

One of the primary goals of sentinel node biopsy is to reduce the need for axillary dissection to minimize a woman’s chance of getting lymphedema, a chronic buildup of fluid that occurs as a result of the body’s impaired ability to drain lymph fluid from tissue.

Radiation techniques have been refined and shortened for women who qualify.